查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1871029

按遞送類型、技術、應用和最終用戶分類的酶促DNA合成市場—2025-2032年全球預測

Enzymatic DNA Synthesis Market by Offering, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，酵素 DNA 合成市場將成長至 12.1377 億美元，複合年成長率為 20.74%。

關鍵市場統計數據
基準年 2024 2.6858億美元
預計年份：2025年 3.1956億美元
預測年份 2032 12.1377億美元
複合年成長率 (%) 20.74%

對酶促DNA合成技術的引入、其科學基礎、工業應用以及相關人員為何應立即參與進行策略概述

酶促DNA合成代表了核苷酸序列構建方式的重大變革，它摒棄了傳統的化學亞磷醯胺法，轉而採用酶方法，有望提高DNA的長度、保真度並減少對環境的影響。本文將讀者置於分子生物學、酶學和工業流程設計的交叉領域，闡述了核心生化機制（模板依賴型連接酶和聚合酵素系統，以及模板非依賴型末端轉移酶策略），並重點介紹了酶工程、流程自動化和整合品管如何融合，從而開啟新的可能性。

酶驅動平台、自動化和計算設計如何改變合成範式，從而實現永續、可擴展和精確的DNA製造

隨著酵素合成方法從實驗室概念驗證發展成為實用化的平台，DNA合成領域正經歷一場變革性的轉變。傳統上，化學合成佔據主導地位，但酵素工程的進步、製程控制的改進以及與自動化和生物資訊學的融合，重塑了DNA合成的價值模式。這些進步消除了危險試劑的使用，並實現了更溫和的反應條件，從而降低了製程複雜性，並為合成更長、更精確的寡核苷酸和構建體鋪平了道路。

對 2025 年美國關稅如何重塑供應鏈、採購方式以及全球取得關鍵合成原料的途徑進行分析性回顧。

2025年美國關稅政策的實施，為支持酵素DNA合成的全球供應鏈增添了新的複雜性，影響了籌資策略、供應商選擇和成本結構。對關鍵物料（例如特種酵素、高純度試劑和資本設備）採購計畫的直接營運影響最為顯著，跨境物流和關稅可能導致交貨時間的波動和延誤。這促使採購團隊重新評估其供應商組合，優先考慮關鍵零件的庫存緩衝，並加快更靠近最終組裝地點的替代供應商的資格認證。

對產品、技術、應用和最終用戶進行詳細的細分分析，以發現促進因素、限制因素和高價值機會。

對市場區隔的深入理解揭示了不同維度——產品、技術、應用和最終用戶——如何驅動不同的需求和投資重點。按產品分類，市場分為「產品」和「服務」。產品包括耗材和試劑盒、DNA合成儀器和平台以及酵素和試劑；服務包括客製化DNA和寡核苷酸合成、基因和DNA文庫合成、誘變和克隆服務以及次世代定序和DNA分析服務。每個細分市場都有不同的創新和收入動態：耗材需要穩定的供應和一致的質量，平台需要資金和生命週期支持，而服務則受吞吐量、品質保證和客戶回應時間的驅動。

影響投資決策、合作模式和應用的區域趨勢（美洲、歐洲、中東和非洲、亞太地區）

區域趨勢將在塑造酶促DNA合成技術在全球市場的應用、商業化和監管方式方面發揮關鍵作用。在美洲，活躍的創投活動、成熟的生物技術叢集以及下游治療藥物研發的巨大需求，為該平台的早期應用創造了有利環境。同時，監管路徑和報銷環境也鼓勵設備供應商和服務實驗室之間的合作。相較之下，歐洲、中東和非洲地區（EMEA）的管理體制、研究資金籌措模式以及公私合營模式各不相同，這些因素影響著該技術的應用速度。在該地區，合規性、跨境合作和永續性標準日益受到重視。

酶促DNA合成領域創新、平台部署和策略聯盟的主要企業的競爭格局和夥伴關係策略

對主要企業的分析表明，酶促DNA合成領域的競爭優勢取決於技術差異化、策略夥伴關係和智慧財產權的綜合作用。主要企業通常將專有的酵素設計技術、平台整合技術以及持續的耗材供應模式結合，從而建立穩定的收入來源。最成功的企業往往也會與學術機構和合約實驗室進行策略合作，檢驗新型化學技術並加速其在實際應用中的推廣。

為產業領導者提供實用指導，以加速酵素DNA合成技術的應用，降低供應鏈風險，並協調研發和商業策略。

希望利用酶促DNA合成技術的產業領導者應採取技術、營運和商業性相結合的措施，以加快價值實現速度並降低執行風險。首先，應優先投資於酵素最佳化和製程分析，以提高合成保真度和循環效率。在生產流程中展現可重複的性能將有助於建立客戶信心並促進技術應用。同時，應開發模組化平台架構和可互通的軟體，以實現增量升級、與實驗室資訊管理系統整合以及順暢的客戶檢驗流程。

透明的調查方法，詳細說明了資料來源、檢驗方法、專家訪談和分析方法，從而得出嚴謹的研究結果。

本分析的調查方法強調透明度、可重複性和多方證據的三角驗證。主要資料來源包括與領域專家的結構化訪談、與平台開發人員和服務供應商的非正式討論，以及揭示實際性能特徵和整合考慮的技術演示。此外，還輔以同行評審文獻、專利申請、監管指導文件和公司披露等二手資訊，以檢驗技術聲明並確定發展路徑。

簡明扼要地總結了各項結論，重點闡述了酶促DNA合成的戰略轉折點及其對科學和工業的長期影響。

這個結論簡潔地概括了分析結果的戰略意義，重點闡述了酶促DNA合成將在科學和工業領域產生最直接和最持久影響的領域。關鍵轉折點包括酶工程和平台整合的成熟、自動化、數位化控制和品管系統的協調一致，以及目前阻礙其廣泛商業化的供應鏈和監管挑戰的解決。這些因素將共同決定酶促合成能否從高潛力示範階段過渡到在研究、診斷和治療藥物生產中的常規應用。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 整合新型聚合酵素工程技術以提高合成準確性和通量
  • 開發用於可擴展DNA組裝的自動化微流體控酶平台
  • 透過引入專有的酵素化學技術，最大限度地減少核苷酸結合錯誤。
  • 擴大高通量酶促DNA合成規模，用於個人化細胞治療分子
  • 生物製藥公司與酵素技術Start-Ups公司之間的策略合作
  • 引入即時品管檢測方法，以確保大規模合成的準確性
  • 影響酶促DNA產品商業化的法規結構的演變

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 酵素DNA合成市場：依產品/服務分類

  • 產品
    • 耗材和套件
    • DNA合成機器與平台
    • 酵素和試劑
  • 服務
    • 客製化DNA和寡核苷酸合成
    • 基因/DNA文庫合成
    • 誘變和克隆服務
    • 次世代定序(NGS) 和 DNA 分析服務

第9章 酶促DNA合成市場：依技術分類

  • 模板依賴類型
    • 基於連接酶的合成
    • 基於聚合酵素的合成
  • 與模板無關
    • 設計的酶
    • 末端脫氧核苷酸轉移酶

第10章 酵素DNA合成市場：依應用分類

  • 農業和工業用途
  • 醫療和診斷應用
  • 藥物研發

第11章 依最終用戶分類的酵素DNA合成市場

  • 學術和研究機構
  • 合約研究組織（CRO）
  • 製藥和生物技術公司

第12章 各地區的酵素DNA合成市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 按組別分類的酵素DNA合成市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國酵素DNA合成市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Aldevron LLC by Danaher Corporation
    • Almac Group Limited
    • Ansa Biotechnologies, Inc.
    • Biotium, Inc.
    • Biozym Scientific GmbH
    • Camena Bioscience
    • CD Genomics
    • DNA Script
    • Evonetix Ltd.
    • Merck KGaA
    • Molecular Assemblies by TriLink BioTechnologies LLC
    • Moligo Technologies AB
    • Stemnovate Limited
    • Telesis Bio Inc.
    • Thermo Fisher Scientific Inc.
    • Touchlight Genetics Limited
    • Twist Bioscience Corporation
Product Code: MRR-1A1A064C059D

The Enzymatic DNA Synthesis Market is projected to grow by USD 1,213.77 million at a CAGR of 20.74% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 268.58 million
Estimated Year [2025] USD 319.56 million
Forecast Year [2032] USD 1,213.77 million
CAGR (%) 20.74%

A strategic overview introducing enzymatic DNA synthesis, its scientific foundations, industrial relevance, and why stakeholders must engage now

Enzymatic DNA synthesis represents a pivotal evolution in how nucleotide sequences are constructed, moving beyond traditional chemical phosphoramidite methods toward enzyme-mediated approaches that promise improvements in length, fidelity, and environmental footprint. This introduction situates the reader at the intersection of molecular biology, enzymology, and industrial process design, explaining the core biochemical mechanisms-template-dependent ligase and polymerase systems and template-independent terminal transferase strategies-while highlighting how enzyme engineering, process automation, and integrated quality control are converging to unlock new capabilities.

The section establishes context by outlining the drivers that make enzymatic approaches strategically relevant: reduced hazardous waste, potential for lower cost-per-base through enzymatic recycling and mild reaction conditions, and opportunities to scale synthesis beyond the constraints of stepwise chemical coupling. It also presents the practical implications for research workflows, diagnostics development, and therapeutic discovery, describing how improved synthesis fidelity and custom sequence capacity enable more complex libraries, longer constructs, and more reliable gene assemblies.

Finally, the introduction frames the remainder of the analysis by identifying the principal stakeholder groups affected by these shifts, including providers of enzymes and platforms, downstream service laboratories, and end users across academia, contract research organizations, and biotech and pharmaceutical companies. This perspective sets expectations for the report's analytical depth and the types of insights stakeholders will find most actionable.

How enzyme-driven platforms, automation, and computational design are shifting synthesis paradigms to enable sustainable, scalable, and precise DNA manufacture

The landscape of DNA synthesis is undergoing transformative shifts as enzyme-based methodologies progress from laboratory proofs of concept to deployable platforms. Historically, chemical synthesis dominated the field, but recent advances in enzyme engineering, improved process control, and integration with automation and bioinformatics have reframed the value equation. These developments reduce hazardous reagents and enable milder reaction conditions, which in turn lower process complexity and create pathways to longer and more accurate oligonucleotides and constructs.

Transitioning from bench to production requires not only robust enzymes but also sophisticated platform design and digital process controls. Integrated hardware and software ecosystems that manage reagent delivery, cycle optimization, and in-line analytical feedback are becoming differentiators. In parallel, computational design tools and error-correction chemistries are accelerating iteration cycles, allowing teams to move from design to validated sequence faster than before. Consequently, companies that can combine optimized enzymes with platform engineering and automated workflows gain substantial competitive advantage.

These shifts also reshape business models: platform vendors, reagent suppliers, and service providers are exploring hybrid offerings that bundle instruments with consumables and analytics services. The cumulative result is a more modular, scalable industry architecture where adaptability, interoperability, and rapid validation become critical success factors for stakeholders aiming to capitalize on enzymatic DNA synthesis.

An analytical review of how 2025 United States tariff measures are reshaping supply chains, procurement approaches, and global access to key synthesis inputs

United States tariff measures enacted in 2025 introduced a new layer of complexity to global supply chains supporting enzymatic DNA synthesis, with implications for procurement strategies, supplier selection, and cost structures. The immediate operational impact is observed in the sourcing timelines for critical inputs such as specialized enzymes, high-purity reagents, and capital equipment where cross-border logistics and customs duties can introduce variability and delay. As a result, procurement teams have re-evaluated supplier portfolios, prioritized inventory buffering for critical components, and accelerated qualification of alternative suppliers closer to final assembly locations.

In addition to operational responses, many organizations revised contractual terms to incorporate greater flexibility, including adjusted lead times, contingency clauses, and destination-based distribution models. Regulatory compliance and documentation have also become more prominent in supplier onboarding, as tariff classifications and origin rules require more granular traceability. Importantly, these policy changes have encouraged stronger collaboration among equipment vendors, reagent manufacturers, and service organizations to develop localized manufacturing options or regional assembly hubs that mitigate exposure to import duties.

Looking forward, the most resilient organizations will be those that combine diversified sourcing strategies with investments in supplier development, nearshoring critical components where feasible, and enhancing supply chain transparency. These measures will reduce operational disruption and help maintain steady access to the reagents, enzymes, and instruments essential for expanded deployment of enzymatic DNA synthesis.

Granular segmentation analysis across offering, technology, application, and end user that reveals drivers, constraints, and high-value opportunities

A nuanced understanding of market segmentation reveals how different dimensions of offering, technology, application, and end user drive distinct needs and investment priorities. By offering, the landscape divides into Products and Services, where Products encompass Consumables & Kits, DNA Synthesizers & Platforms, and Enzymes & Reagents, while Services include Custom DNA & Oligo Synthesis, Gene & DNA Library Synthesis, Mutagenesis & Cloning Services, and Next-Generation Sequencing and DNA Analysis Services. Each of these subsegments follows different innovation and revenue dynamics: consumables demand steady supply and quality consistency, platforms require capital and lifecycle support, and service offerings depend on throughput, quality assurance, and customer turnaround times.

From a technology perspective, the market separates along Template Dependent and Template Independent approaches. Template Dependent modalities include ligase-based and polymerase-based synthesis, which are often aligned with workflows requiring templated elongation and controlled sequence fidelity. Template Independent approaches, represented by engineered enzymes and terminal deoxynucleotidyl transferase strategies, offer flexibility for certain library constructions and non-templated extensions, often supporting novel assay formats and bespoke constructs.

Application-driven differences further stratify priorities into Agricultural & Industrial Uses, Medical & Diagnostic Applications, and Pharmaceutical & Drug Development. Each application segment imposes specific regulatory, scale, and validation requirements that influence technical roadmaps. Finally, end users such as Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies adopt distinct procurement and adoption timelines, with research institutions often piloting novel methods, CROs emphasizing reproducibility and throughput, and commercial firms prioritizing scalability and regulatory readiness. Understanding these layered segmentations enables more precise product development and commercialization strategies.

Regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence investment decisions, collaboration models, and adoption

Regional dynamics play a decisive role in shaping how enzymatic DNA synthesis technologies are adopted, commercialized, and regulated across global markets. In the Americas, robust venture activity, established biotech clusters, and significant downstream demand for therapeutic development create fertile conditions for early platform adoption, while regulatory pathways and reimbursement environments encourage collaborations between instrument vendors and service laboratories. In contrast, Europe, Middle East & Africa present a mosaic of regulatory regimes, research funding patterns, and public-private partnership models that influence adoption cadence; here, emphasis often centers on compliance, cross-border collaborations, and sustainability standards.

Asia-Pacific combines rapidly growing capacity, significant public investment in life sciences, and strong manufacturing ecosystems that can accelerate scale-up and cost optimization. This region also demonstrates increasing capabilities in enzyme engineering and localized reagent production, reducing dependence on distant suppliers. Across all regions, differences in supply chain maturity, talent availability, and regulatory frameworks create heterogeneity in go-to-market strategies and partnership models. Consequently, firms seeking global reach should pursue region-specific strategies that account for local procurement practices, regulatory validation timelines, and the presence of clusters that can accelerate trials and early commercial deployments.

Ultimately, strategic investors and corporate leaders must align regional entry plans with local innovation ecosystems, leveraging partnerships and localized operations to mitigate trade-related risks and to capture the fastest-growing use cases.

Competitive profiles and partnership strategies of leading companies advancing enzymatic DNA synthesis innovation, platform rollout, and strategic collaborations

Key company insights emphasize the convergence of technological differentiation, strategic partnerships, and intellectual property as determinants of competitive positioning in enzymatic DNA synthesis. Leading organizations typically combine proprietary enzyme engineering, platform integration expertise, and recurring consumables models to create defensible revenue streams. In many cases, the most successful firms also pursue strategic collaborations with academic centers and contract laboratories to validate novel chemistries and to accelerate real-world use cases.

Partnership strategies are increasingly important; alliances with component suppliers, automation specialists, and analytical providers enable end-to-end solutions that reduce customer integration burden. Moreover, joint development agreements and licensing arrangements facilitate faster route-to-market for new enzyme variants or platform modules while spreading development risk. On the commercial side, companies are experimenting with hybrid revenue models that mix instrument sales, reagent subscriptions, and high-value services to align incentives across the value chain.

From an organizational perspective, companies that invest in rigorous quality systems, regulatory expertise, and scalable manufacturing processes are better positioned to transition from early adopters to broader market acceptance. Risk management practices, including diversified supply chains and contingency planning, further distinguish those able to maintain continuity of supply and service as enzymatic approaches become more widely adopted.

Actionable guidance for industry leaders to accelerate adoption, de-risk supply chains, and align R&D with commercial strategies for enzymatic DNA synthesis

Industry leaders seeking to capitalize on enzymatic DNA synthesis should adopt a combination of technological, operational, and commercial actions to accelerate value creation and reduce execution risk. First, prioritize investments in enzyme optimization and process analytics to improve fidelity and cycle efficiency; demonstrating reproducible performance in real-world workflows will drive customer trust and broader adoption. Concurrently, develop modular platform architectures and interoperable software that enable incremental upgrades, integration with laboratory information management systems, and smoother customer validation pathways.

Operationally, diversify supplier networks for critical reagents and consider regional manufacturing or assembly to mitigate tariff and logistics exposure. Strengthen supplier qualification processes and contractual terms to incorporate contingency planning. On the commercial front, expand pilot programs with strategic customers across academic, CRO, and pharmaceutical segments to gather application-specific validation data and to co-create service offerings that address distinct throughput and quality needs.

Finally, align corporate development with long-term goals by evaluating partnerships, licensing, and selective M&A that bring complementary capabilities in enzyme engineering, automation, or analytics. These combined actions will enable industry leaders to accelerate adoption, de-risk scale-up, and turn technological advances into sustainable commercial advantage.

A transparent research methodology detailing data sources, validation practices, expert interviews, and analytical approaches that yield rigorous insights

The research methodology underpinning this analysis emphasizes transparency, reproducibility, and triangulation across multiple evidence streams. Primary data sources included structured interviews with subject-matter experts, informal consultations with platform developers and service providers, and technology demonstrations that revealed practical performance characteristics and integration considerations. Secondary sources complemented these insights through peer-reviewed literature, patent filings, regulatory guidance documents, and company disclosures that together helped validate technical claims and identify developmental trajectories.

To ensure analytical rigor, data were cross-validated using multiple methods: qualitative interview inputs were compared with observed platform specifications, and claims about enzyme performance were assessed against independent validation studies where available. The approach also incorporated a thematic synthesis of regulatory and supply chain variables to contextualize technology adoption risks. Where uncertainties existed, sensitivity-driven scenario analysis and expert elicitation informed the interpretation of likely outcomes rather than quantitative forecasts.

Throughout, emphasis was placed on methodological clarity: assumptions are documented, evidence provenance is maintained, and limitations are explicitly acknowledged so that readers can interpret findings in light of specific organizational priorities and risk tolerances.

A concise synthesis of conclusions that underscore strategic inflection points and the long-term implications of enzymatic DNA synthesis for science and industry

The conclusion synthesizes the analysis into a concise set of strategic takeaways that highlight where enzymatic DNA synthesis will have the most immediate and durable impact across science and industry. Key inflection points include the maturation of enzyme engineering and platform integration; the alignment of automation and digital controls with quality systems; and the resolution of supply chain and regulatory hurdles that currently slow broader commercialization. Together, these factors determine whether enzyme-based synthesis moves from high-potential demonstrations to routine use in research, diagnostics, and therapeutic manufacturing.

For organizations already engaged with DNA synthesis workflows, the implication is clear: proactively evaluate enzymatic approaches through targeted pilots that emphasize analytical validation, cost-to-implement, and workflow interoperability. For investors and corporate strategists, the focus should be on companies demonstrating deep enzyme IP, scalable platform architectures, and defensible consumables models. Finally, for policymakers and infrastructure stakeholders, supporting local manufacturing capabilities, streamlined regulatory pathways, and collaborative validation frameworks will accelerate safe and equitable access to these technologies.

In sum, enzymatic DNA synthesis is poised to reshape key aspects of sequence construction and application. The pace and breadth of that change will depend on coordinated action across technology developers, end users, and supporting institutions to validate performance, ensure supply resilience, and align commercial models with real-world needs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of novel polymerase engineering to enhance synthesis fidelity and throughput
  • 5.2. Development of automated microfluidic enzymatic platforms for scalable DNA assembly
  • 5.3. Adoption of proprietary enzymatic chemistries to minimize nucleotide coupling errors
  • 5.4. Expansion of high-throughput enzymatic DNA synthesis for personalized cell therapy molecules
  • 5.5. Strategic partnerships between biopharma companies and enzyme technology startups
  • 5.6. Implementation of real-time quality control assays to ensure synthesis accuracy at scale
  • 5.7. Regulatory framework developments impacting commercialization of enzymatic DNA products

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Enzymatic DNA Synthesis Market, by Offering

  • 8.1. Products
    • 8.1.1. Consumables & Kits
    • 8.1.2. DNA Synthesizers & Platforms
    • 8.1.3. Enzymes & Reagents
  • 8.2. Services
    • 8.2.1. Custom DNA & Oligo Synthesis
    • 8.2.2. Gene & DNA Library Synthesis
    • 8.2.3. Mutagenesis & Cloning Services
    • 8.2.4. Next-Generation Sequencing (NGS) & DNA Analysis Services

9. Enzymatic DNA Synthesis Market, by Technology

  • 9.1. Template Dependent
    • 9.1.1. Ligase Based Synthesis
    • 9.1.2. Polymerase Based Synthesis
  • 9.2. Template Independent
    • 9.2.1. Engineered Enzymes
    • 9.2.2. Terminal Deoxynucleotidyl Transferase

10. Enzymatic DNA Synthesis Market, by Application

  • 10.1. Agricultural & Industrial Uses
  • 10.2. Medical & Diagnostic Applications
  • 10.3. Pharmaceutical & Drug Development

11. Enzymatic DNA Synthesis Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Contract Research Organizations (CROs)
  • 11.3. Pharmaceutical & Biotechnology Companies

12. Enzymatic DNA Synthesis Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Enzymatic DNA Synthesis Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Enzymatic DNA Synthesis Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Aldevron LLC by Danaher Corporation
    • 15.3.2. Almac Group Limited
    • 15.3.3. Ansa Biotechnologies, Inc.
    • 15.3.4. Biotium, Inc.
    • 15.3.5. Biozym Scientific GmbH
    • 15.3.6. Camena Bioscience
    • 15.3.7. CD Genomics
    • 15.3.8. DNA Script
    • 15.3.9. Evonetix Ltd.
    • 15.3.10. Merck KGaA
    • 15.3.11. Molecular Assemblies by TriLink BioTechnologies LLC
    • 15.3.12. Moligo Technologies AB
    • 15.3.13. Stemnovate Limited
    • 15.3.14. Telesis Bio Inc.
    • 15.3.15. Thermo Fisher Scientific Inc.
    • 15.3.16. Touchlight Genetics Limited
    • 15.3.17. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ENZYMATIC DNA SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ENZYMATIC DNA SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ENZYMATIC DNA SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONSUMABLES & KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONSUMABLES & KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONSUMABLES & KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONSUMABLES & KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONSUMABLES & KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONSUMABLES & KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DNA SYNTHESIZERS & PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DNA SYNTHESIZERS & PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DNA SYNTHESIZERS & PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DNA SYNTHESIZERS & PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DNA SYNTHESIZERS & PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DNA SYNTHESIZERS & PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES & REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES & REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES & REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES & REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES & REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CUSTOM DNA & OLIGO SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CUSTOM DNA & OLIGO SYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CUSTOM DNA & OLIGO SYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CUSTOM DNA & OLIGO SYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CUSTOM DNA & OLIGO SYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CUSTOM DNA & OLIGO SYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GENE & DNA LIBRARY SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GENE & DNA LIBRARY SYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GENE & DNA LIBRARY SYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GENE & DNA LIBRARY SYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GENE & DNA LIBRARY SYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GENE & DNA LIBRARY SYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MUTAGENESIS & CLONING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MUTAGENESIS & CLONING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MUTAGENESIS & CLONING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MUTAGENESIS & CLONING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MUTAGENESIS & CLONING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MUTAGENESIS & CLONING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) & DNA ANALYSIS SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) & DNA ANALYSIS SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) & DNA ANALYSIS SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) & DNA ANALYSIS SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) & DNA ANALYSIS SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) & DNA ANALYSIS SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIGASE BASED SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIGASE BASED SYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIGASE BASED SYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIGASE BASED SYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIGASE BASED SYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIGASE BASED SYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY POLYMERASE BASED SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY POLYMERASE BASED SYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY POLYMERASE BASED SYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY POLYMERASE BASED SYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY POLYMERASE BASED SYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY POLYMERASE BASED SYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENGINEERED ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENGINEERED ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENGINEERED ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENGINEERED ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENGINEERED ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENGINEERED ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY AGRICULTURAL & INDUSTRIAL USES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY AGRICULTURAL & INDUSTRIAL USES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY AGRICULTURAL & INDUSTRIAL USES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY AGRICULTURAL & INDUSTRIAL USES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY AGRICULTURAL & INDUSTRIAL USES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY AGRICULTURAL & INDUSTRIAL USES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MEDICAL & DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MEDICAL & DIAGNOSTIC APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MEDICAL & DIAGNOSTIC APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MEDICAL & DIAGNOSTIC APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MEDICAL & DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MEDICAL & DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & DRUG DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & DRUG DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & DRUG DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & DRUG DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & DRUG DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE DEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TEMPLATE INDEPENDENT, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PRODUCTS, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY